UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 107 filers reported holding UROGEN PHARMA LTD in Q4 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $176 | +11.4% | 10,500 | 0.0% | 0.03% | +3.3% |
Q1 2024 | $158 | 0.0% | 10,500 | 0.0% | 0.03% | -11.8% |
Q4 2023 | $158 | -99.9% | 10,500 | 0.0% | 0.03% | -10.5% |
Q3 2023 | $147,105 | +51.6% | 10,500 | 0.0% | 0.04% | +15.2% |
Q2 2023 | $97,020 | 0.0% | 10,500 | 0.0% | 0.03% | +10.0% |
Q1 2023 | $97,020 | +4.2% | 10,500 | 0.0% | 0.03% | -6.2% |
Q4 2022 | $93,135 | – | 10,500 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 1,155,862 | $38,571,000 | 11.13% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 849,478 | $28,347,000 | 4.49% |
Horton Capital Management, LLC | 108,670 | $3,626,000 | 3.53% |
Prosight Management, LP | 217,686 | $7,264,000 | 3.19% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $98,598,000 | 2.35% |
Phoenix Holdings Ltd. | 834,739 | $27,663,000 | 1.16% |
SHIKIAR ASSET MANAGEMENT INC | 67,025 | $2,237,000 | 0.74% |
MEITAV INVESTMENT HOUSE LTD | 272,063 | $9,080,000 | 0.66% |
Clal Insurance Enterprises Holdings Ltd | 17,666 | $529,388,000 | 0.57% |
Migdal Insurance & Financial Holdings Ltd. | 738,302 | $24,637,000 | 0.48% |